Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06115083
Other study ID # K 2023-4671
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date December 2026

Study information

Verified date April 2024
Source Region Stockholm
Contact Lotta Renström Koskela, M.D
Phone +46-8-12370000
Email lotta.renstrom-koskela@regionstockholm.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this randomized controlled study is to establish the long-term effect of pelvic floor re-education using biofeedback and home training for men with chronic pelvic pain. The main questions it aims to answer are if pelvic floor re-education using bio-feedback and home training will give a long-lasting improvement in symptoms, assessed with a validated symptom score (the National Institute of Health - Chronic Prostatitis Symptom Index) and if an improvement in symptoms can be correlated to objective measurements of pelvic floor function. Participants will be asked to do pelvic floor exercises daily during six months with additional sessions of bio-feedback training. The control group will have no changes in their on-going treatment for their chronic pelvic pain and will be offered to enter the treatment group after six months.


Description:

At baseline all included study subjects will fill in a validated symptom score, the National Institute of Health - Chronic Prostatitis Symptom Index (NIH-CPSI) and have an assessment of their pelvic floor muscles and undergo a urodynamic evaluation. The intervention group will perform short daily session of pelvic floor muscle training at home during six months in combination with four bio-feedback sessions during the first months. The study subjects will receive an individual instruction based on the pelvic floor assessment from the baseline visit. The study subjects will report their training in a digital diary. A reevaluation will be done at three, six and twelve months. At six and 12 months repeating the baseline tests. At three months a renewed assessment of muscle function and the NIH-CPSI questionnaire. The control group will be instructed not to engage in any new treatment for their chronic pelvic pain during the study period. After the six months evaluation all participants in the control group will be offered to be enrolled in the treatment group, with the same set-up and follow-up as the treatment group.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Men over the age of 18, residents in Sweden, diagnosed with Chronic Primary Pelvic Pain Syndrome (CPPPS) according to the International Statistical Classification of Diseases and Related Health Problems (ICD-10) (N41.1 (chronic prostatitis), N41.9 (Inflammatory disease of prostate, unspecified), N50.8F (Chronic Pelvic Pain Syndrome in men) Exclusion Criteria: - Cancer in the abdomen or pelvic organs (current or previous) - Congenital anomalies affecting the pelvic region (Bladder exstrophy, Myelomeningocele etc.) - Transsexual male, (i.e. at birth biologically female) - Diseases affecting the nerve function to the pelvic and/or lower extremities, other disease or ongoing treatment that could have an impact on the outcome of the study. - Incapability to participate in testing or follow training instructions due to mental incapacity, language difficulties etc.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pelvic floor re-education using bio-feedback and home training
Pelvic floor re-education using bio-feedback and home training

Locations

Country Name City State
Sweden Karolinska University Hospital Stockholm

Sponsors (2)

Lead Sponsor Collaborator
Region Stockholm Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in symptom score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire Change in total score, range from 0-43 points. Higher score indicates worse symptoms. Measured 3, 6 and 12 months after inclusion
Secondary Change in sub score on the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire Sub score according to the domains; pain 0-21, urological symptoms 0-10 points and quality of life impact 0-12 points. Higher score indicates worse symptoms in all three domains. Measured 3, 6 and 12 months after inclusion
Secondary Changes in global voiding function using free flow non-invasive urodynamic testing Changes in global voiding function using free flow non-invasive urodynamic testing with electromyogram.
Global assessment where combined results from maximum urinary flow rate, voided volume, post voiding residual volume, pelvic floor activity during voiding and the shape of the curve are used to define types of voiding patterns.
Normal flow
Asymmetrical obstructive flow
Symmetrical low flow
Irregular curve, straining flow
Plateau low flow
As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams.
Measured 6 and 12 months after inclusion
Secondary Changes in global storing function of the bladder using invasive urodynamics, cystometry Changes in global bladder function using invasive urodynamics with cystometry with electromyogram.
Global assessment where combined results from sensory input, cystometric capacity, detrusor activity, compliance and pelvic floor activity are combined to define different patterns.
Normal cystometry
Abnormal sensory input
Detrusor activity
Abnormal compliance
Abnormal bladder capacity
As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams.
Measured 6 and 12 months after inclusion
Secondary Changes in global voiding function using invasive urodynamics, pressure-flow study Changes in global voiding function using invasive urodynamics, pressure-flow study with electromyogram.
Global assessment where combined results from detrusor contractility, urinary flow and pelvic floor activity are combined to define different patterns.
Normal flow
Under-active flow
Obstructed flow
As described in the International Continence Society good urodynamic practices recommendations 2018 and Urodynamics (third edition) by P. Abrams.
Measured 6 and 12 months after inclusion
Secondary Changes in urethral pressure using invasive urodynamics, urethral pressure profile Changes in urethral pressure using invasive urodynamics, urethral pressure profile.
Maximum urethral pressure (cmH2O)
Maximum urethral closure pressure (cmH2O)
As described in Urodynamics (third edition) by P. Abrams.
Measured 6 and 12 months after inclusion
Secondary Changes in pelvic floor muscle assessment according to test specifics by Frawley et al 2021 and the modified Oxford Scale according to Laycock et al 2001. Pelvic floor muscle assessment according to test specifics by Frawley et al 2021
Assessment of muscle tone
- Decreased / normal / increased
Assessment of voluntary contraction
- No contraction / correct contraction / contraction only with help from other muscles / uncertain / straining
Assessment of relaxation post contraction
- Yes / partial or delayed / no
Assessment of tenderness
Yes / No
If yes location is noted and severity of pain is graded according to numeric rating scale, 0-10, with higher value indicatinge more severe pain.
Modified Oxford Scale for assessment of pelvic floor muscle power, graded from 0-5 with higer value indicating stronger power.
Measured 3, 6 and 12 months after inclusion
Secondary Correlation between subjective and objective measurements Correlation between subjective measurements using the National Institute of Health-Chronic Prostatitis Symptom Index questionnaire and objective findings on urodynamic testing and pelvic floor assessment. Measured 3, 6 and 12 months after inclusion
See also
  Status Clinical Trial Phase
Recruiting NCT05868668 - Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain N/A
Completed NCT05546203 - Trigger Point Treatment in Chronic Pelvic Pain N/A
Recruiting NCT05926752 - Photobiomodulation for Myofascial Pelvic Pain N/A
Completed NCT00775281 - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. N/A
Recruiting NCT06209346 - Multimodal Physiotherapy Based on Tele-rehabilitation in Chronic Pelvic Pain Associated With Endometriosis N/A
Terminated NCT01879930 - Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study Phase 4
Completed NCT00688506 - Combined Sono-electro-magnetic Therapy for Treatment of Refractory Chronic Pelvic Pain Syndrome N/A
Completed NCT00922012 - Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome N/A
Completed NCT00434343 - Physical Therapy Trial for Pelvic Pain N/A
Recruiting NCT03641807 - Different Modes of Assessment on Acupuncture Effect on Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome N/A
Completed NCT00710073 - Sono-Electro-Magnetic Therapy for Refractory Chronic Pelvic Pain Syndrome N/A
Completed NCT01843946 - Clinical Efficacy of Roxithromycin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome N/A
Completed NCT04549389 - The Ideal LiST Session Frequency Protocol for CPPS Treatment N/A
Recruiting NCT06161805 - Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study Phase 3
Not yet recruiting NCT06168058 - Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices N/A
Completed NCT01738464 - Microbiomes of Pelvic Pain
Completed NCT01391338 - A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) Phase 2
Not yet recruiting NCT06445790 - Efficacy of Cognitive Behavior Therapy in the Treatment of Chronic Pelvic Pain in Women N/A
Recruiting NCT05754190 - Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Completed NCT06038773 - Social and Clinical Aspects of Pelvic Pain in Turkey